packageLuspatercept

luspatercept

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Luspatercept is an antianemic medicine used to treat anemia in people with myelodysplastic syndromes or beta-thalassemia. It is authorised in the European Union and is also being studied for further uses.

Summary written by glm-5.3-flash from Wikidata Q30314143 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:luspatercept
ATC codes:B03XA06
DrugBank:DB12281
Wikidata:Q30314143
molar mass:76000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown